Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

(2015) Donato Iacovazzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion

(2015) Cuiqi Zhou et al.   JOURNAL OF CLINICAL INVESTIGATION

Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth

(2014) Takashi Nomiyama et al.   DIABETES

A Novel C-terminal Nonsense Mutation, Q315X, of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in a Japanese Familial Isolated Pituitary Adenoma Family

(2014) Takeo Iwata et al.   ENDOCRINE PATHOLOGY

AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling

(2014) I Tuominen et al.   ONCOGENE

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene

(2013) Albert Beckers et al.   ENDOCRINE REVIEWS

Aip regulates cAMP signalling and GH secretion in GH3 cells

(2013) R Formosa et al.   ENDOCRINE-RELATED CANCER

Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition

(2013) Rhodri M. L. Morgan et al.   PLoS One

Multiplex Genome Engineering Using CRISPR/Cas Systems

(2013) L. Cong et al.   SCIENCE

Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients

(2012) Laure Cazabat et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway

(2012) Harvinder S. Chahal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas

(2011) Maria A Tichomirowa et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry

(2011) Sandrine Fieffe et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Mice with Inactivation of Aryl Hydrocarbon Receptor-Interacting Protein (Aip) Display Complete Penetrance of Pituitary Adenomas with Aberrant ARNT Expression

(2010) Anniina Raitila et al.   AMERICAN JOURNAL OF PATHOLOGY

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ZAC1 target genes and pituitary tumorigenesis

(2010) Marily Theodoropoulou et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Inhibition of 5α-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice

(2010) Shubham Gupta et al.   PROSTATE

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)

(2010) Harvinder S. Chahal et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer

(2009) Bharat B. Aggarwal et al.   Annals of the New York Academy of Sciences

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

(2009) Marie-Lise Jaffrain-Rea et al.   ENDOCRINE-RELATED CANCER

Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly

(2009) Marily Theodoropoulou et al.   INTERNATIONAL JOURNAL OF CANCER

Acromegaly pathogenesis and treatment

(2009) Shlomo Melmed   JOURNAL OF CLINICAL INVESTIGATION

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

(2008) Chrysanthia A. Leontiou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line

(2007) Simona Grozinsky-Glasberg et al.   NEUROENDOCRINOLOGY